David C. Sachs Immunity Bio, Inc. (IBRX) insider trading activity
David C. Sachs is Chief Financial Officer of ImmunityBio, Inc.. Currently has a direct ownership of 225,620 shares of IBRX, which is worth approximately $708,446. The most recent transaction as insider was on Feb 22, 2025, when has been sold 15,860 shares (Common Stock) at a price of $3.42 per share, resulting in proceeds of $54,241. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
226K
12.34%
3M change
21.41%
12M change
Total Value Held
$708,446
David C. Sachs Transaction History
DCS
David C. Sachs
Chief Financial Officer
San Diego, CA